|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Z, Qian W, Wang S, Ji D, Wang Q, Li
J, Peng W, Gu J, Hu T, Ji B, et al: Analysis of lncRNA-Associated
ceRNA network reveals potential lncRNA biomarkers in human colon
adenocarcinoma. Cell Physiol Biochem. 49:1778–1791. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thrumurthy SG, Thrumurthy SS, Gilbert CE,
Ross P and Haji A: Colorectal adenocarcinoma: Risks, prevention and
diagnosis. BMJ. 354:i35902016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang H, Du J, Gu J, Jin L, Pu Y and Fei
B: A 65 gene signature for prognostic prediction in colon
adenocarcinoma. Int J Mol Med. 41:2021–2027. 2018.PubMed/NCBI
|
|
5
|
Yang Y, Li XJ, Li P and Guo XT:
MicroRNA-145 regulates the proliferation, migration and invasion of
human primary colon adenocarcinoma cells by targeting MAPK1. Int J
Mol Med. 42:3171–3180. 2018.PubMed/NCBI
|
|
6
|
Tsukuda K, Tanino M, Soga H, Shimizu N and
Shimizu K: A novel activating mutation of the K-ras gene in human
primary colon adenocarcinoma. Biochem Biophys Res Commun.
278:653–658. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arnaout MA: Integrin structure: New twists
and turns in dynamic cell adhesion. Immunol Rev. 186:125–140. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tadokoro S, Shattil SJ, Eto K, Tai V,
Liddington RC, de Pereda JM, Ginsberg MH and Calderwood DA: Talin
binding to integrin beta tails: A final common step in integrin
activation. Science. 302:103–106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ginsberg MH, Partridge A and Shattil SJ:
Integrin regulation. Curr Opin Cell Biol. 17:509–516. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Campbell ID and Humphries MJ: Integrin
structure, activation, and interactions. Cold Spring Harb Perspect
Biol. 3:a0049942011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Larson RS, Corbi AL, Berman L and Springer
T: Primary structure of the leukocyte function-associated
molecule-1 alpha subunit: An integrin with an embedded domain
defining a protein superfamily. J Cell Biol. 108:703–712. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Humphries JD, Byron A and Humphries MJ:
Integrin ligands at a glance. J Cell Sci. 119:3901–3903. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oxvig C and Springer TA: Experimental
support for a beta-propeller domain in integrin alpha-subunits and
a calcium binding site on its lower surface. Proc Natl Acad Sci
USA. 95:4870–4875. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goodman SL and Picard M: Integrins as
therapeutic targets. Trends Pharmacol Sci. 33:405–412. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shattil SJ, Kim C and Ginsberg MH: The
final steps of integrin activation: The end game. Nat Rev Mol Cell
Biol. 11:288–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moser M, Nieswandt B, Ussar S, Pozgajova M
and Fassler R: Kindlin-3 is essential for integrin activation and
platelet aggregation. Nat Med. 14:325–330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen B, Delaney MK and Du X: Inside-out,
outside-in, and inside-outside-in: G protein signaling in
integrin-mediated cell adhesion, spreading, and retraction. Curr
Opin Cell Biol. 24:600–606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Legate KR, Wickstrom SA and Fassler R:
Genetic and cell biological analysis of integrin outside-in
signaling. Genes Dev. 23:397–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schwartz MA and Ginsberg MH: Networks and
crosstalk: Integrin signalling spreads. Nat Cell Biol. 4:E65–E68.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hehlgans S, Haase M and Cordes N:
Signalling via integrins: Implications for cell survival and
anticancer strategies. Biochim Biophys Acta. 1775:163–180.
2007.PubMed/NCBI
|
|
24
|
Ryu J, Koh Y, Park H, Kim DY, Kim DC, Byun
JM, Lee HJ and Yoon SS: Highly expressed integrin-alpha8 induces
epithelial to mesenchymal transition-like features in multiple
myeloma with early relapse. Mol Cells. 39:898–908. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo WH, Bian JJ, Tian GF, Lyu ZX, Gui YX
and Ye L: Expression of fermintin family homologous protein 2 in
non-small cell lung cancer and its clinical significance. Zhonghua
Bing Li Xue Za Zhi. 47:780–783. 2018.(In Chinese; Abstract
available in Chinese from the publisher). PubMed/NCBI
|
|
26
|
Haas TL, Sciuto MR, Brunetto L, Valvo C,
Signore M, Fiori ME, di Martino S, Giannetti S, Morgante L, Boe A,
et al: Integrin alpha7 is a functional marker and potential
therapeutic target in glioblastoma. Cell stem cell. 21:35–50.e9.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong L, Zheng Y, Liu S and Peng Z:
Fibronectin regulates the dynamic formation of ovarian cancer
multicellular aggregates and the expression of integrin receptors.
Asian Pac J Cancer Prev. 19:2493–2498. 2018.PubMed/NCBI
|
|
28
|
Chang HW, Yen CY, Chen CH, Tsai JH, Tang
JY, Chang YT, Kao YH, Wang YY, Yuan SF and Lee SY: Evaluation of
the mRNA expression levels of integrins alpha3, alpha5, beta1 and
beta6 as tumor biomarkers of oral squamous cell carcinoma. Oncol
Lett. 16:4773–4781. 2018.PubMed/NCBI
|
|
29
|
Ji J, Chen H, Liu XP, Wang YH, Luo CL,
Zhang WW, Xie W and Wang FB: A miRNA combination as promising
biomarker for hepatocellular carcinoma diagnosis: A study based on
bioinformatics analysis. J Cancer. 9:3435–3446. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar
|
|
31
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gene Ontology Consortium, . The Gene
Ontology (GO) project in 2006. Nucleic Acids Res. 34:D322–D326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maere S, Heymans K and Kuiper M: BiNGO: A
cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mostafavi S, Ray D, Warde-Farley D,
Grouios C and Morris Q: GeneMANIA: A real-time multiple association
network integration algorithm for predicting gene function. Genome
Biol. 9 (Suppl 1):S42008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Yu T, Liao X, Yang C, Han C, Zhu
G, Huang K, Yu L, Qin W, Su H, et al: The prognostic value of CYP2C
subfamily genes in hepatocellular carcinoma. Cancer Med. 7:966–980.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstrale M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liberzon A, Birger C, Thorvaldsdottir H,
Ghandi M, Mesirov JP and Tamayo P: The molecular signatures
database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Reiner A, Yekutieli D and Benjamini Y:
Identifying differentially expressed genes using false discovery
rate controlling procedures. Bioinformatics. 19:368–375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Benjamini Y, Drai D, Elmer G, Kafkafi N
and Golani I: Controlling the false discovery rate in behavior
genetics research. Behav Brain Res. 125:279–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Caswell PT and Norman JC: Integrin
trafficking and the control of cell migration. Traffic. 7:14–21.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiong J, Balcioglu HE and Danen EH:
Integrin signaling in control of tumor growth and progression. Int
J Biochem Cell Biol. 45:1012–1015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Felding-Habermann B, Mueller BM, Romerdahl
CA and Cheresh DA: Involvement of integrin alpha V gene expression
in human melanoma tumorigenicity. J Clin Invest. 89:2018–2022.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang Q, Bavi P, Wang JY and Roehrl MH:
Immuno-proteomic discovery of tumor tissue autoantigens identifies
olfactomedin 4, CD11b, and integrin alpha-2 as markers of
colorectal cancer with liver metastases. J Proteomics. 168:53–65.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Waisberg J, De Souza Viana L, Affonso
Junior RJ, Silva SR, Denadai MV, Margeotto FB, De Souza CS and
Matos D: Overexpression of the ITGAV gene is associated with
progression and spread of colorectal cancer. Anticancer Res.
34:5599–5607. 2014.PubMed/NCBI
|
|
49
|
Liu X, Tian H, Li H, Ge C, Zhao F, Yao M
and Li J: Derivate Isocorydine (d-ICD) suppresses migration and
invasion of hepatocellular carcinoma cell by downregulating ITGA1
expression. Int J Mol Sci. 18(pii): E5142017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rosenberg EE, Prudnikova TY, Zabarovsky
ER, Kashuba VI and Grigorieva EV: D-glucuronyl C5-epimerase cell
type specifically affects angiogenesis pathway in different
prostate cancer cells. Tumour Biol. 35:3237–3245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chuang YC, Wu HY, Lin YL, Tzou SC, Chuang
CH, Jian TY, Chen PR, Chang YC, Lin CH, Huang TH, et al: Blockade
of ITGA2 induces apoptosis and inhibits cell migration in gastric
cancer. Biol Proced Online. 20:102018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gong J, Lu X, Xu J, Xiong W, Zhang H and
Yu X: Coexpression of UCA1 and ITGA2 in pancreatic cancer cells
target the expression of miR-107 through focal adhesion pathway. J
Cell Physiol. 234:12884–12896. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lu Y, Li C, Chen H and Zhong W:
Identification of hub genes and analysis of prognostic values in
pancreatic ductal adenocarcinoma by integrated bioinformatics
methods. Mol Biol Rep. 45:1799–1807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lemma SA, Kuusisto M, Haapasaari KM,
Sormunen R, Lehtinen T, Klaavuniemi T, Eray M, Jantunen E, Soini Y,
Vasala K, et al: Integrin alpha 10, CD44, PTEN, cadherin-11 and
lactoferrin expressions are potential biomarkers for selecting
patients in need of central nervous system prophylaxis in diffuse
large B-cell lymphoma. Carcinogenesis. 38:812–820. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pan Y, Liu G, Yuan Y, Zhao J, Yang Y and
Li Y: Analysis of differential gene expression profile identifies
novel biomarkers for breast cancer. Oncotarget. 8:114613–114625.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang R, Zhang TT, Zhai GQ, Guo XY, Qin Y,
Gan TQ, Zhang Y, Chen G, Mo WJ and Feng ZB: Evaluation of the
HOXA11 level in patients with lung squamous cancer and insights
into potential molecular pathways via bioinformatics analysis.
World J Surg Oncol. 16:1092018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Parajuli H, The MT, Abrahamsen S,
Christoffersen I, Neppelberg E, Lybak S, Osman T, Johannessen AC,
Gullberg D, Skarstein K and Costea DE: Integrin alpha11 is
overexpressed by tumour stroma of head and neck squamous cell
carcinoma and correlates positively with alpha smooth muscle actin
expression. J Oral Pathol Med. 46:267–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kok-Sin T, Mokhtar NM, Ali Hassan NZ,
Sagap I, Mohamed Rose I, Harun R and Jamal R: Identification of
diagnostic markers in colorectal cancer via integrative epigenomics
and genomics data. Oncol Rep. 34:22–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yang X, Deng Y, He RQ, Li XJ, Ma J, Chen G
and Hu XH: Upregulation of HOXA11 during the progression of lung
adenocarcinoma detected via multiple approaches. Int J Mol Med.
42:2650–2664. 2018.PubMed/NCBI
|
|
60
|
Shang L, Ye X, Zhu G, Su H, Su Z, Chen B,
Xiao K, Li L, Peng M and Peng T: Prognostic value of integrin
variants and expression in post-operative patients with HBV-related
hepatocellular carcinoma. Oncotarget. 8:76816–76831. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Haider S, Wang J, Nagano A, Desai A,
Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF,
Kocher HM, et al: A multi-gene signature predicts outcome in
patients with pancreatic ductal adenocarcinoma. Genome Med.
6:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yan P, He Y, Xie K, Kong S and Zhao W: In
silico analyses for potential key genes associated with gastric
cancer. PeerJ. 6:e60922018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zheng W, Jiang C and Li R: Integrin and
gene network analysis reveals that ITGA5 and ITGB1 are prognostic
in non-small-cell lung cancer. Onco Targets Ther. 9:2317–2327.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mallawaaratchy DM, Buckland ME, McDonald
KL, Li CC, Ly L, Sykes EK, Christopherson RI and Kaufman KL:
Membrane proteome analysis of glioblastoma cell invasion. J
Neuropathol Exp Neurol. 74:425–441. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Maschler S, Wirl G, Spring H, Bredow DV,
Sordat I, Beug H and Reichmann E: Tumor cell invasiveness
correlates with changes in integrin expression and localization.
Oncogene. 24:2032–2041. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yang J and Wang N: Analysis of the
molecular mechanism of osteosarcoma using a bioinformatics
approach. Oncol Lett. 12:3075–3080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Fang ZQ, Zang WD, Chen R, Ye BW, Wang XW,
Yi SH, Chen W, He F and Ye G: Gene expression profile and
enrichment pathways in different stages of bladder cancer. Genet
Mol Res. 12:1479–1489. 2013. View Article : Google Scholar : PubMed/NCBI
|
